Cantargia AB is a biotechnology company headquartered in Lund, Sweden. It specializes in developing antibody-based treatments for cancer and autoimmune diseases.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Cantargia →Already a subscriber? Sign in
Xcout Intel tracks Cantargia continuously — this profile deepens as new filings, funding, people and hiring data arrive.